MultiplAI Health

Curated by Signal

Developer of an AI-enabled in vitro diagnostic system for the detection of cancer

Life Sciences Technologymultiplaihealth.com

Overview

Developer of an AI-enabled in vitro diagnostic system for the detection of cancer. The company has developed a non-invasive whole blood screening test that uses RNA sequencing and artificial intelligence for the detection of cancer. The company uses RNA sequencing, bioinformatic processing, deep learning, and algorithm analysis for the identification of disease-causing biomarkers in the blood.

Key facts

Founded: 2019
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

4 products and services: Sign up to view

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Metrichor
Provider of software platform for real-time analysis of nano-pore sequencing data
Life Sciences TechnologyOxford, United Kingdom
HealthSTATS
Radial pulse wave aquisition device for 24-hour blood pressure monitoring
Life Sciences TechnologyLondon, United Kingdom
Labskin
Developer of human skin models
Life Sciences TechnologyYork, United Kingdom

About MultiplAI Health

What does MultiplAI Health do?

Developer of an AI-enabled in vitro diagnostic system for the detection of cancer.

Where is MultiplAI Health headquartered?

MultiplAI Health is headquartered in London, United Kingdom.

When was MultiplAI Health founded?

MultiplAI Health was founded in 2019.

Which sector is MultiplAI Health in?

MultiplAI Health operates in Life Sciences Technology.

Who are MultiplAI Health's competitors?

Companies similar to MultiplAI Health include Metrichor, HealthSTATS, and Labskin.